Chester County News and Community Website
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced its financial results for the fourth quarter and fiscal year 2024, alongside significant corporate updates. The biotechnology company reaffirmed its commitment …
Arbutus Biopharma Reports 2024 Financial Results and Strategic Updates Read More
NEWTON, PA — Traws Pharma, Inc. (NASDAQ: TRAW) is set to host a virtual investor event on Monday, March 31, 2025, at 10:00 AM ET, where the company will spotlight its …
Traws Pharma Announces Virtual Investor Event to Showcase Innovative Treatments for Bird Flu and COVID-19 Read More
YARDLEY, PA — Optinose (NASDAQ: OPTN) has announced its financial results for the year and quarter ending December 31, 2024, spotlighting strong growth in XHANCE prescriptions and revenue. The company also …
Optinose Reports 2024 Financial Results, Highlights Prescription Growth and First Operational Income Read More NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled promising preclinical and Phase 1 data for ratutrelvir, its investigational oral treatment for COVID-19. Presented at the International Conference for …
Traws Pharma Announces Promising Data for Ratutrelvir as a COVID-19 Treatment Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has announced its fourth-quarter and full-year 2024 financial results, highlighting unprecedented growth in revenue, gross profit, and operational milestones.
NEXGEL Reports Record-Breaking 2024 Financial Performance Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced it has successfully regained compliance with The Nasdaq Stock Market LLC’s minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This ensures …
Windtree Therapeutics Regains Nasdaq Compliance Read More NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) announced encouraging topline results from preclinical studies evaluating tivoxavir marboxil (TXM) as a potential treatment for H5N1 bird flu. The investigational oral therapy, …
Traws Pharma Reports Promising Preclinical Results for Bird Flu Treatment Read More
BRISTOL, PA — TESCO has unveiled the T3 Turbo Meter Tester, a cutting-edge solution designed to simplify and enhance meter testing for utilities. This lightweight, portable device allows technicians to …
TESCO Introduces Field-Testing Innovation with T3 Turbo Meter Tester and 6330 Analyzer Read More
NEWTOWN, PA — David Navazio, President and CEO of Gentell, has been named the recipient of the 2025 Baldrige Foundation Award for Leadership Excellence. This prestigious award recognizes individuals who …
David Navazio to Receive 2025 Baldrige Foundation Award for Leadership Excellence Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE), a clinical-stage biopharmaceutical company, shared its financial results for 2024 and provided a progress update on its lead programs aimed at advancing cancer …
Aprea Therapeutics Reports 2024 Financial Results and Updates on Clinical Innovations Read More